Phase 3 Topline Results 'Disappointing' for Novel Antidepressant as Monotherapy - Medscape

Submitted by Anonymous (not verified) on Fri, 10/14/2022 - 18:32

Phase 3 Topline Results 'Disappointing' for Novel Antidepressant as Monotherapy  Medscape